Publications
- Predictive factors for a severe course of COVID-19 infection in myasthenia gravis patients with an overall impact on myasthenic outcome status and survival +12021 | First Faculty of Medicine
- Is no evidence of disease activity an achievable goal in MS patients on intramuscular interferon beta-1a treatment over long-term follow-up?2017 | First Faculty of Medicine
- Combining clinical and magnetic resonance imaging markers enhances prediction of 12-year disability in multiple sclerosis2017 | First Faculty of Medicine
- Relationship between gray matter volume and cognitive learning in CIS patients on disease-modifying treatment2014 | First Faculty of Medicine
- Volumetric MRI Markers and Predictors of Disease Activity in Early Multiple Sclerosis: A Longitudinal Cohort Study2012 | First Faculty of Medicine
- Immunity following SARS-CoV-2 vaccination in autoimmune neurological disorders treated with rituximab or ocrelizumab2023 | First Faculty of Medicine
- Current and future therapeutic options for the treatment of the generalized form of myasthenia gravis2023 | First Faculty of Medicine
- To be or not to be vaccinated: The risk of MS or NMOSD relapse after COVID-19 vaccination and infection2022 | First Faculty of Medicine
- Measurement of neurofilaments improves stratification of future disease activity in early multiple sclerosis2021 | Faculty of Physical Education and Sport, First Faculty of Medicine
- Neurofilament levels are associated with blood-brain barrier integrity, lymphocyte extravasation, and risk factors following the first demyelinating event in multiple sclerosis2021 | First Faculty of Medicine
Loading network view...
